Our system is currently under heavy load due to increased usage. We're actively working on upgrades to improve performance. Thank you for your patience.
2022
DOI: 10.3390/healthcare10071190
|View full text |Cite
|
Sign up to set email alerts
|

Metabolic Comorbidities and Cardiovascular Disease in Pediatric Psoriasis: A Narrative Review

Abstract: Psoriasis vulgaris is a common inflammatory, immune mediated, chronic recurrent dermatosis. Psoriasis is also a systemic inflammatory disease, associated with numerous comorbidities, particularly metabolic ones. Here, we summarize and discuss, in a narrative review, the current knowledge about the metabolic comorbidities in psoriatic children. Obesity, insulin resistance, diabetes, cardiovascular disease, and dyslipidemia are identified as the main comorbidities in psoriatic children. In conclusion, dermatolog… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
3
1
1

Citation Types

0
7
0
1

Year Published

2022
2022
2024
2024

Publication Types

Select...
7

Relationship

4
3

Authors

Journals

citations
Cited by 10 publications
(11 citation statements)
references
References 29 publications
0
7
0
1
Order By: Relevance
“…Pediatric patients with AD are at a higher risk to develop metabolic comorbidities, such as obesity, arterial hypertension, and dyslipidaemia. These disorders are usually underestimated, and are associated with long term sequelae and an increased risk of cardiovascular event, which may occur also later, in adult age, as demonstrated in patients with psoriasis or lichen planus [ 50 , 53 , 54 , 55 ].…”
Section: Discussionmentioning
confidence: 99%
“…Pediatric patients with AD are at a higher risk to develop metabolic comorbidities, such as obesity, arterial hypertension, and dyslipidaemia. These disorders are usually underestimated, and are associated with long term sequelae and an increased risk of cardiovascular event, which may occur also later, in adult age, as demonstrated in patients with psoriasis or lichen planus [ 50 , 53 , 54 , 55 ].…”
Section: Discussionmentioning
confidence: 99%
“…Die Betrachtung der Psoriasis als Systemerkrankung gründet sich auf die Beobachtung, dass zumindest bei Patienten mit mittelschwerer und schwerer Psoriasis proinflammatorische Zytokine nicht nur in der Haut, sondern auch im peripheren Blut erhöht sind und hierdurch der Weg für zahlreiche Komorbiditäten gebahnt wird. Von besonderer Bedeutung im Kindes- und Jugendalter ist die Adipositas, die bereits in dieser frühen Lebensphase nicht nur die Wahrscheinlichkeit der Manifestation einer Psoriasis erhöht, sondern deren Ausprägung auch mit einer schweren Form der Psoriasis korreliert ist [ 13 ].…”
Section: Komorbiditätenunclassified
“…Patients with moderate-to-severe psoriasis show subclinical inflammation in the liver, joints, and tendons, in addition to significantly increased global arterial and subcutaneous inflammation [ 6 , 7 , 8 , 9 ]. In fact, systemic elevations in plasma levels of cytokines promote chronic subclinical inflammation associated with arthritis, cardiovascular comorbidities, and metabolic syndromes, such as obesity, dyslipidemia, diabetes, and atherosclerosis [ 10 ]. These associations have been also shown in psoriatic children.…”
Section: Introductionmentioning
confidence: 99%